Pod Save America Hosts Call on Democrats to Cut All Israel Military Aid, No Longer Accept AIPAC Funding
Jews, Israelis Targeted in Austria Amid Surge in Antisemitic Incidents; Local Jewish Community Calls for Action
‘All of Our Strength’: Over 1,000 Pro-Israel Activists Gather in DC for Solidarity Conference
‘Devastated’: Wesley LePatner, Killed in Manhattan Mass Shooting, Was a Jewish Communal, Philanthropic Leader
Sen. Angus King Vows to No Longer Vote for Israel Military Aid Until Gaza Conditions Improve
Europe Won’t Pressure Israel to ‘Commit Suicide’ Amid Gaza Backlash, Palestinian State Push, Says Israeli FM
Israel’s National Soccer Coach Attacked in Athens Before Soccer Fans Chant ‘F–K Israel, Free Palestine’ at Match
New York Judge Sentences Neo-Nazi to 5 Years for Livestreaming Bomb Threats Against Jewish Hospitals
US Pressures Lebanon to Issue Cabinet Decision to Disarm Hezbollah Before Talks Continue
UK Plans to Recognize Palestinian State in September Unless Israel Meets Conditions, Starmer Says
Report: Nearly 1 in 3 Israelis Refuse COVID-19 Treatment Pill
Error: Contact form not found.
by i24 News and Algemeiner Staff
Paxlovid, a Pfizer’s coronavirus disease (COVID-19) pill, is seen manufactured in Ascoli, Italy, in this undated handout photo obtained by Reuters on Nov. 16, 2021. Photo: Pfizer/Handout via Reuters
i24 News – Roughly one in three Israelis offered Pfizer’s COVID-19 treatment pill Paxlovid refused to take the drug, according to a report published Tuesday.
Israel began distributing the first COVID-19 treatment pill to at-risk patients on Sunday, and about 1,000 people started taking it, according to Channel 12 News.
However, while Paxlovid was found to be very effective in preventing the virus from becoming severe among patients, some 400 eligible people refused to take it.
Due to limited medical supplies, only patients considered to be at high risk can receive the drug.
Doron Netzer of Israel’s Clalit Health Services told Channel 12 News that some half of those who were offered the pill at his Health Maintenance Organization declined it.
“When we look into it, it turns out most people believe their illness is mild, and so even though they are at high-risk levels, they refuse to get the treatment,” Netzer said.
In December, the US Food and Drug Administration approved Paxlovid, which can be taken at home, after Pfizer clinical trials showed that it was nearly 90 percent effective in preventing hospitalizations and deaths in patients at high risk of developing severe illness.
The first shipment of the pills landed in Israel on Dec. 30, making the Jewish state one of the first countries to receive the new treatment.
Israel ordered 100,000 doses of Paxlovid overall as its healthcare system rushes to combat the surge of the highly contagious omicron variant.
On Wednesday, Israel registered 43,815 new COVID-19 cases amid the country’s fifth wave.
